Aquaculture Vaccines Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-07-20　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 0.72 Bn
2033 年預估規模: USD 1.39 Bn
年複合成長率 CAGR: 9.9%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-07-20頁數 250報告編號 CMI9811

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Aquaculture Vaccines Market, By Species (Fish, Crustaceans, Mollusks, and Others), By Vaccine Type (Inactivated (Killed) Vaccines, Live Attenuated Vaccines, DNA Vaccines, and Others), By Pathogen Type (Bacterial Vaccines, Viral Vaccines, Parasitic Vaccines, and Others), By End User (Commercial Aquaculture Farms, Hatcheries, Research Institutes and Universities, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global aquaculture vaccines market is estimated to be valued at USD 0.72 Bn in 2026 and is expected to reach USD 1.39 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033. The global aquaculture vaccines market is a significant aspect of the animal health industry as it caters to the need to sustainably grow fish and aquatic organisms, preventing the widespread infectious diseases. The demand for fish is escalating as aquaculture expands globally due to the diminishing populations of wild fish. However, such expansion has raised concerns about potential fish diseases. Aquaculture vaccines help in minimizing and prevention of disease outbreak in farmed species, thereby reducing costs and enhancing the growth and overall well-being of the farmed species. Vaccines have proved to be an excellent replacement for antibiotics, a less costly as well as an environment friendly solution for the prevention of bacterial, viral and parasitic diseases in farmed aquatic animals. Vaccines can be administered through injection, oral ingestion, or by immersion. These have seen substantial growth in popularity due to stringent policies of governments towards the reduction of antibiotic use. Market Dynamics The global aquaculture vaccines market is driven by the increasing production of aquaculture, growing global seafood demand, and the prevalence of aquatic disease. Furthermore, increasing restrictions over antibiotic use coupled with growing focus towards sustainable aquaculture practices is fueling up the market for vaccines. Besides this, development of recombinant, DNA based, adjuvant-based vaccines enhance vaccine efficiency and protection of major bacterial as well as viral diseases. However, a number of constraints are present in the market, such as high vaccine development and administration costs, limited availability of vaccines for several commercially farmed species, and inadequate veterinary infrastructure in developing regions. Nevertheless, expanding commercial aquaculture industry in Latin America, Africa as well as the Asia Pacific region, growing preference for antibiotic free seafood and innovation related to oral and thermo-stable vaccines are expected to provide lucrative opportunities for the market participants. Key Features of the Study • This report provides in-depth analysis of the global aquaculture vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global aquaculture vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Zoetis Inc., Merck Animal Health, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, HIPRA, Virbac, Benchmark Holdings plc, Tecnovax S.A., Kyoto Biken Laboratories, Inc., and Nisseiken Co., Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global aquaculture vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aquaculture vaccines market Market Segmentation • Species Insights (Revenue, USD Bn, 2021 - 2033) o Fish o Crustaceans o Mollusks o Others • Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033) o Inactivated (Killed) Vaccines o Live Attenuated Vaccines o DNA Vaccines o Others • Pathogen Type Insights (Revenue, USD Bn, 2021 - 2033) o Bacterial Vaccines o Viral Vaccines o Parasitic Vaccines o Others • End User Insights (Revenue, USD Bn, 2021 - 2033) o Commercial Aquaculture Farms o Hatcheries o Research Institutes and Universities o Others • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Zoetis Inc. o Merck Animal Health o Elanco Animal Health Incorporated o Phibro Animal Health Corporation o HIPRA o Virbac o Benchmark Holdings plc o Tecnovax S.A. o Kyoto Biken Laboratories, Inc. o Nisseiken Co., Ltd.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Aquaculture Vaccines Market, By Species  Global Aquaculture Vaccines Market, By Vaccine Type  Global Aquaculture Vaccines Market, By Pathogen Type  Global Aquaculture Vaccines Market, By End User  Global Aquaculture Vaccines Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Aquaculture Vaccines Market, By Species, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Fish  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Crustaceans  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Mollusks  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Aquaculture Vaccines Market, By Vaccine Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Inactivated (Killed) Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Live Attenuated Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o DNA Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Aquaculture Vaccines Market, By Pathogen Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Bacterial Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Viral Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Parasitic Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Aquaculture Vaccines Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Commercial Aquaculture Farms  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Hatcheries  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Research Institutes and Universities  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Aquaculture Vaccines Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Species, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Pathogen Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o Zoetis Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck Animal Health  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Elanco Animal Health Incorporated  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Phibro Animal Health Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o HIPRA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Virbac  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Benchmark Holdings plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Tecnovax S.A.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Kyoto Biken Laboratories, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Nisseiken Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 10. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Aquaculture Vaccines Market' - Global forecast to 2033

提及公司

Zoetis Inc.Merck Animal HealthElanco Animal Health IncorporatedPhibro Animal Health CorporationHIPRAVirbacBenchmark Holdings plcTecnovax S.A.Kyoto Biken Laboratories, Inc.Nisseiken Co., Ltd.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們